Free Trial

Millennium Management LLC Buys 3,687,613 Shares of Haleon PLC Sponsored ADR $HLN

Haleon logo with Medical background

Key Points

  • Millennium Management LLC significantly increased its stake in Haleon PLC, raising its position by 697.2% to over 4.2 million shares valued at approximately $43.4 million as of the latest SEC filing.
  • Haleon announced a new semi-annual dividend of $0.0555 per share, reflecting an increase from its previous dividend of $0.05, with a payment date set for September 18th.
  • Equities analysts have shown mixed sentiment, with BNP Paribas Exane upgrading Haleon to an "outperform" rating and setting a price target of $13.40, while Wall Street Zen downgraded it from "buy" to "hold".
  • Five stocks to consider instead of Haleon.

Millennium Management LLC grew its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 697.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,216,504 shares of the company's stock after buying an additional 3,687,613 shares during the quarter. Millennium Management LLC owned approximately 0.09% of Haleon worth $43,388,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hancock Whitney Corp bought a new stake in shares of Haleon in the 1st quarter valued at about $120,000. Banque Transatlantique SA acquired a new position in Haleon in the 1st quarter valued at about $27,000. Bain Capital Public Equity Management II LLC grew its stake in Haleon by 8.8% in the 1st quarter. Bain Capital Public Equity Management II LLC now owns 3,093,270 shares of the company's stock valued at $31,830,000 after buying an additional 249,260 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Haleon by 22.5% during the 1st quarter. AQR Capital Management LLC now owns 96,323 shares of the company's stock worth $991,000 after purchasing an additional 17,720 shares in the last quarter. Finally, Cubist Systematic Strategies LLC grew its position in shares of Haleon by 243.4% during the 1st quarter. Cubist Systematic Strategies LLC now owns 1,447,922 shares of the company's stock worth $14,899,000 after purchasing an additional 1,026,291 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on HLN. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. The Goldman Sachs Group raised shares of Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Finally, BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price for the company in a research note on Tuesday, May 27th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $12.33.

Read Our Latest Stock Analysis on Haleon

Haleon Stock Performance

HLN stock traded down $0.07 during mid-day trading on Friday, hitting $9.81. The company had a trading volume of 7,825,877 shares, compared to its average volume of 7,791,135. The stock's fifty day moving average price is $9.73 and its two-hundred day moving average price is $10.20. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. The firm has a market cap of $43.89 billion, a PE ratio of 25.14, a price-to-earnings-growth ratio of 2.90 and a beta of 0.23.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be paid a $0.0555 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a yield of 190.0%. This is a boost from Haleon's previous semi-annual dividend of $0.05. Haleon's dividend payout ratio is presently 28.21%.

About Haleon

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Stories

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.